Outsmarting Complex Diseases With Smarter Medicines
Senti Bio (sentibio.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 70th percentile of 19322 Healthcare brands.
Senti Bio is a biotechnology company operating in the healthcare sector that develops cell therapies using proprietary Gene Circuit technology rooted in synthetic biology. Its stated mission is to create more intelligent medicines capable of outsmarting complex diseases, with its lead candidate, SENTI-202, targeting acute myeloid leukemia. The company positions itself as a pioneer in gene circuit engineering for next-generation cancer therapeutics, aiming to serve oncology patients, clinicians, researchers, and biopharma partners interested in advanced cell therapy solutions.
| Brand Name | Senti Bio |
|---|---|
| Domain | sentibio.com |
| Industry | Healthcare |
| Main Competitors | Precision BioSciences (76/100), Intellia Therapeutics (84/100), Cellectis (81/100), Allogene Therapeutics (83/100), Arcellx (82/100), Caribou Biosciences (76/100) |
Moz Domain Authority 35/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,274,848 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Outsmarting Complex Diseases With More Intelligent Medicines" (Meta description: 7 words. OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Senti Bio?", Claude could identify the brand as of October 2026. Senti Bio (Senti Biosciences) is a clinical-stage biotech company developing gene and cell therapies using synthetic biology, particularly logic-gated CAR-NK and CAR-T cell therapies designed to more precisely target cancer cells while sparing healthy tissue. Best known for Developing 'gene circuit' logic-gated cell therapies for cancer using synthetic biology platforms.
When asked "Best brands similar to Senti Bio?", Claude would recommend Senti Bio as of October 2026. It's a recognized name in the synthetic biology and engineered cell therapy space, especially for its logic-gated CAR-NK approach, so it would be relevant if discussing innovative cancer cell therapy companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Senti Bio's main competitors in Healthcare: Precision BioSciences (76/100), Intellia Therapeutics (84/100), Cellectis (81/100), Allogene Therapeutics (83/100), Arcellx (82/100).
Sources: Brand Analyzer scan
Senti Bio has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 39, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Senti Bio official site
Senti Bio scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Senti Bio official site
Senti Bio offers cell therapies engineered with its proprietary Gene Circuit technology. Its lead product candidate is SENTI-202, a cell therapy being developed for the treatment of acute myeloid leukemia.
Sources: Senti Bio official site
Senti Bio is a biotechnology company that develops cell therapies for complex diseases, particularly cancer, using synthetic biology and proprietary Gene Circuit technology.
Sources: Senti Bio official site
Senti Bio engineers cell therapies by programming cells with Gene Circuits, a synthetic biology approach designed to make therapies more targeted and effective. Its lead program, SENTI-202, is being developed for acute myeloid leukemia.
Sources: Senti Bio official site
Senti Bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Senti Bio official site
Senti Bio is known for its Gene Circuit technology, a synthetic biology platform used to engineer differentiated cell therapies, and for its lead candidate SENTI-202, aimed at treating acute myeloid leukemia.
Sources: Senti Bio official site
Senti Bio's work is intended for oncology patients, particularly those with acute myeloid leukemia, as well as clinicians, researchers, and biopharma partners interested in advanced cell therapy development.
Sources: Senti Bio official site
Senti Bio scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Senti Bio has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #3,274,848 (Tranco), open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 35/100. In a live check, Claude could already identify Senti Bio from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Senti Bio: SensoScientific (79/100), Sensely (79/100), SEQENS (79/100), ServiceNet (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.